253 related articles for article (PubMed ID: 22461695)
1. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.
Yang D; Torres CM; Bardhan K; Zimmerman M; McGaha TL; Liu K
J Immunol; 2012 May; 188(9):4441-9. PubMed ID: 22461695
[TBL] [Abstract][Full Text] [Related]
2. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
Paschall AV; Yang D; Lu C; Choi JH; Li X; Liu F; Figueroa M; Oberlies NH; Pearce C; Bollag WB; Nayak-Kapoor A; Liu K
J Immunol; 2015 Aug; 195(4):1868-82. PubMed ID: 26136424
[TBL] [Abstract][Full Text] [Related]
3. TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.
Liu F; Hu X; Zimmerman M; Waller JL; Wu P; Hayes-Jordan A; Lev D; Liu K
PLoS One; 2011 Jan; 6(1):e16241. PubMed ID: 21264227
[TBL] [Abstract][Full Text] [Related]
4. Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA.
Brodská B; Otevřelová P; Holoubek A
Mol Cell Biochem; 2011 Apr; 350(1-2):71-80. PubMed ID: 21153863
[TBL] [Abstract][Full Text] [Related]
5. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro.
Abou Najem S; Khawaja G; Hodroj MH; Rizk S
Curr Mol Pharmacol; 2019; 12(4):281-300. PubMed ID: 30868973
[TBL] [Abstract][Full Text] [Related]
7. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.
Konkankit VV; Kim W; Koya RC; Eskin A; Dam MA; Nelson S; Ribas A; Liau LM; Prins RM
J Transl Med; 2011 Nov; 9():192. PubMed ID: 22060015
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
9. Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.
Coe GL; Redd PS; Paschall AV; Lu C; Gu L; Cai H; Albers T; Lebedyeva IO; Liu K
Sci Rep; 2016 Aug; 6():30816. PubMed ID: 27487939
[TBL] [Abstract][Full Text] [Related]
10. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells.
Lou YF; Zou ZZ; Chen PJ; Huang GB; Li B; Zheng DQ; Yu XR; Luo XY
PLoS One; 2014; 9(5):e97719. PubMed ID: 24874286
[TBL] [Abstract][Full Text] [Related]
11. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
Nagarkatti N
Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
[TBL] [Abstract][Full Text] [Related]
13. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.
Liu F; Liu Q; Yang D; Bollag WB; Robertson K; Wu P; Liu K
Cancer Res; 2011 Nov; 71(21):6807-16. PubMed ID: 21911457
[TBL] [Abstract][Full Text] [Related]
14. 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
Ghanim V; Herrmann H; Heller G; Peter B; Hadzijusufovic E; Blatt K; Schuch K; Cerny-Reiterer S; Mirkina I; Karlic H; Pickl WF; Zöchbauer-Müller S; Valent P
Blood; 2012 May; 119(18):4242-52. PubMed ID: 22438247
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
16. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage.
Premkumar DR; Jane EP; Agostino NR; DiDomenico JD; Pollack IF
Mol Carcinog; 2013 Feb; 52(2):118-33. PubMed ID: 22086447
[TBL] [Abstract][Full Text] [Related]
18. Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
Cai Z; Yang F; Yu L; Yu Z; Jiang L; Wang Q; Yang Y; Wang L; Cao X; Wang J
J Immunol; 2012 Jun; 188(12):5954-61. PubMed ID: 22573809
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand promotes tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cell Cycle; 2006 Feb; 5(3):246-9. PubMed ID: 16418579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]